Introduction
evolves there is a need for less invasive more ultrasoundbased programmes, which will reduce overall costs from Pituitary desensitization with gonadotrophin-releasing hormone biochemical testing. In the latter stages of cycles, the role of (GnRH) analogues prior to ovarian stimulation, enhances preg-CFD has already been investigated in monitoring folliculonancy rates after IVF and embryo transfer (Serafini et al., 1988;  genesis and oocyte recovery (Balakier and Stronell, 1994; Hughes et al., 1992) and is widely employed. Currently success- Oyesanya et al., 1996; Nargund et al., 1996) . Studies excluful pituitary down-regulation is assessed by suppression of sively on the effects of GnRH analogues on pelvic blood flow pituitary and ovarian hormones and/or measurement of endoin assisted reproduction treatment cycles are lacking. metrial thickness.
In this prospective longitudinal study, the blood flow changes More recently however, the use of transvaginal sonography that occur at down-regulation after GnRH analogue usage and pulsed colour Doppler velocimetry has made it possible were investigated to establish whether colour flow Doppler to identify and quantify blood flow in pelvic vessels with can be used to monitor satisfactory pituitary suppression. satisfactory reproducibility (Tekay and Joupilla, 1996) . Colour flow Doppler (CFD) studies have demonstrated a correlation between pelvic blood flow and serum oestrogen and Materials and methods progesterone (Jauniaux et al., 1992; Glock and Brumsted, This prospective longitudinal study was carried out on 75 consecutive 1995). They have also been used to investigate the relationship patients who were undergoing assisted reproduction treatment between between pelvic blood flow and IVF outcome (Weiner et al., January 1998 and October 1998 in the Assisted Conception Unit at 1993; Tekay et al., 1995; Bloechle et al., 1997; Engmann St James's University Hospital, Leeds, UK, and was approved by our et al., 1999) . Hormonal changes that occur during downinstitution's local ethics committee. The mean age of the patients was regulation may modulate ovarian and uterine blood flow 33 .2 years (range 28-42 years). Thirty-two patients had IVF treatment, through their action on oestrogen receptors present on smooth 20 patients frozen-thawed embryo transfer cycles and 23 patients muscle cells on pelvic vasculature (Berquist et al., 1993) and were recipients for oocyte donation cycles. No patients with polycystic can also be analysed with Doppler velocimetry.
ovaries were included in the study because polycystic ovaries are associated with different ovarian and uterine haemodynamics when Furthermore as cycle monitoring in assisted reproduction compared with non-polycystic ovaries (Zaidi et al., 1998) . All patients to eliminate low frequency signals and the pulse repetition frequency at 2-10 kHz. The spatial peak temporal average intensity (SPTA) had a body mass index (BMI) of ഛ32kg/m 2 , with no systemic or pelvic disease, nor were any patients with ovarian cysts Ͼ10 mm was Ͻ80 mW/cm 2 , within safety limits set by the American Institute of Ultrasound in Medicine (AIUM, 1992) . included at the baseline scan. All recipients of donated oocytes had not received any hormonal therapy 2 months prior to their treatment Initially B-mode grey scale sonography was used to examine ovarian and uterine morphology. The ovarian volume was calculated cycle. The patients in the study underwent the same long protocol of down-regulation. This involved pituitary desensitization with either from three maximum measurements of: the longitudinal (D1), anteroposterior (D2) and transverse (D3) diameters, scanning in sagittal buserelin acetate (Hoechst, Hounslow, Middlesex, UK) (n ϭ 23), at a dose of 0.5 mg s.c. daily or nafarelin intranasal spray (Searle, High and coronal planes. The ovarian volume was obtained using the formula for the volume of a prolate ellipsoid: D1ϫD2ϫD3ϫ0.52. Wycombe, Bucks, UK), (n ϭ 52), 200 µg 8 hourly from the first day of the menstrual cycle and continued for 21 days. Use of either Endometrial thickness was calculated as the distance between the superior and inferior endometrial-myometrial interface, excluding the analogue was decided by patient preference.
The baseline scan was performed on each patient within 3 days echoless zone. The ovarian arteries were identified at the superio-lateral border of of the start of the ongoing treatment menstrual cycle and the prestimulation scan after 21 days of down-regulation with a GnRH each ovary with colour flow and the signal interrogated with pulsed Doppler (Figure 1 ).Occasionally the ovarian artery signal was not analogue. The following were recorded: (i) the ovarian volume (both right and left ovaries), (ii) endometrial thickness and (iii) Doppler clear and the sample volume was moved across the ovary until a clear signal was identified. The ovarian signals were recognized by estimations of the (right and left) ovarian arteries and the mean (right and left) ascending uterine arteries as described below.
low velocity and high impedance helping to distinguish them from the other vessels in proximity (Kurjak and Kupesic, 1995) . Each A venous blood sample was also obtained for estimation of serum oestradiol, progesterone, follicle-stimulating hormone (FSH) and ascending branch of the uterine artery was identified, lateral to the cervix and waveform patterns generated. In all Doppler scans alteration luteinizing hormone (LH) at the time of scanning.
There is at present no definitive data for optimum oestradiol of the angle of insonation produced maximum colour density so that at least three waveform patterns were analysed for measurement of concentrations after the down-regulation phase and cut-off values vary widely (Porcu et al., 1995; Bloechle et al., 1997; Barash et al., the pulsatility index (PI), resistance index (RI), peak systolic velocity (PSV) and the time averaged maximum velocity (TAMX), which 1998). Satisfactory down-regulation was defined by a cut-off value for oestradiol of ഛ130 pmol/l (~35 pg/ml) (Dada et al., 1999) .
were all determined by the ultrasound software.
Hormone assays Transvaginal colour Doppler velocimetry
Interobserver variability was eliminated by a single operator (TD) Serum FSH and LH were measured in all samples using a Technicon Immuno 1 automated clinical analyser employing a sandwich scanning all the patients in this study and all Doppler scans were carried out at the same time of day (0800-1200 h) to eliminate immunoassay format, with a detection limit of 0.1 mIU/l (Bayer Diagnostics, Newbury, Berks, UK). Serum oestradiol and progesterdiurnal variation (Zaidi et al., 1995) .
All scans were performed in the lithotomy position with an empty one assays used a similar kit (Bayer Diagnostics) employing a competitive immunoassay format with a detection limit of 37 pmol/l bladder utilizing a 5 MHz transvaginal probe with colour and pulsed Doppler facilities (Aloka SSD-1700; Aloka Corporation, Tokyo, and 0.4 nmol/l respectively. The inter-assay CV for FSH, LH, oestradiol and progesterone were 4, 4.6, 6.2 and 7.8% while the intra-assay CV Japan). A pilot study of 20 patients was performed to determine reproducibility of blood flow measurements in the ovarian and uterine were 3.2, 4.5, 5.1 and 9.3% respectively. vessels. In this study each patient was scanned as described above Statistical analysis and uterine and ovarian artery Doppler measurements obtained. The operator was blinded to these results and the patients rescanned after Statistical analysis was carried out using the Statistical Package for Social Sciences (SPSS) version seven and results expressed as meañ5 min (Tekay and Joupilla, 1996) . The coefficient of variation (CV) for the ovarian and uterine flows was Ͻ12% for all Doppler parameters Ϯ SD. Analysis of variance (ANOVA) of replicate measurements was employed for reproducibility data. The Student's t-test was used and the interclass correlation coefficients (ICC) ranged between 0.86-0.98 for both arteries (Bland and Altman, 1992) .
to test for equality of means, the Wilcoxon matched-pairs signed rank test for non-normally distributed data and ANOVA to compare age For all Doppler scans, the high pass wall filter was set at 50 Hz and specificities calculated. A P value of Ͻ0.05 was considered to be statistically significant. Table I shows the changes in hormone profile, ovarian volume Doppler waveforms for evaluation were obtained from all the and endometrial thickness during down-regulation. The mean patients in the study.
Results of hormone profile, endometrial thickness and ovarian volume changes after down-regulation Results
serum hormone concentrations decreased from baseline to preThe mean ages for the IVF, frozen-thawed embryo transfer stimulation and these changes were significant in oestradiol, and oocyte donation cycles groups of patients were 30.4 Ϯ 4, progesterone and LH. Although there was a fall in the mean 31.2 Ϯ 3 and 38.2 Ϯ 3 years respectively. Patients undergoing FSH concentration, this did not reach statistical significance. oocyte donation treatment were significantly older (P Ͻ 0.05) Mean pre-stimulation oestradiol values were below the defined than the two other groups.
cut-off value of 130 pmol/l. Initial evaluation of right and left ascending uterine arteries
The baseline ovarian volumes in both right and left ovaries showed no significant differences between the two and so for were comparable as were the post GnRH analogue volumes. the purposes of the study the mean uterine artery flow has
There was a significant decrease in ovarian volumes after been used.
pituitary desensitization (P Ͻ 0.001) in both ovaries and There were no patients with ovarian cysts Ͼ10 mm at the endometrial thickness fell significantly (P Ͻ 0.0001) over the baseline scan included in the study and a non-significant down-regulation period. increased incidence of remnant corpus luteum (CL) cysts was found in the left ovary compared with the right (53 versus
Comparison of Doppler measurements at baseline and pre-47%). Also, comparison of blood flow in ovaries with and stimulation without remnant CL cysts revealed a marginally higher flow Table II shows how Doppler measurements changed over the down-regulation period. Impedance studies (RI and PI) showed a significant (P Ͻ 0.05) increase in resistance over the study The percentage changes in ovarian and uterine blood flow Baseline: ഛ3 days before menstruation of treatment cycle; pre-stimulation:
were compared after 21 days of down-regulation with nafarelin after 21 days of gonadotrophin-releasing hormone (GnRH) analogue use.
(n ϭ 23) versus buserelin (n ϭ 52) administration. There were FSH: follicle stimulating hormone; LH: luteinizing hormone; NS: nonsignificant. no significant differences in the changes in blood flow between All values are mean Ϯ SD. BL ϭ baseline; PS ϭ pre-stimulation; RI ϭ resistance index; PI ϭ pulsatility index; PSV ϭ peak systolic velocity; TAMX ϭ time average maximum velocity. a A significant difference P Ͻ 0.05 between baseline and pre-stimulation values.
buserelin and nafarelin when all Doppler parameters were ഛ130 pmol/l. At this oestradiol value the best cut-off desensitization values were calculated for the tests above. compared. Figure 2 shows the mean percentage change in Doppler measurements in ovarian vasculature.
The results show that in this study population, ET and Doppler resistance indices appear to be the best tests, with RI Comparison of age groups superior to PI. An ideal test with 100% sensitivity and 100% specificity Table III shows the effect of age on the Doppler measurements in the ovarian and uterine arteries. There was no significant would have an area under the ROC curve of 1. If the test has no discriminatory power whatever, the ROC curve will be a difference in either the baseline or pre-stimulation Doppler PI or PSV when comparing the age groups of ഛ30, 31-35 or straight line and the area under the curve will be 0.5 and at any given cut-off value the chances of a true-positive and a Ͼ35 years.
false-positive would be equal. With a sensitivity of~90% Developing discriminatory cut-off values for satisfactory and positive predictive value of~97%, the resistance index down-regulation discriminatory cut-off values for satisfactory suppression of ovarian blood flow in the right and left ovarian arteries was Tables IVa and b, list the results of receiver operating characteristic (ROC) curves calculated for each of the parameters:-0.841 and 0.805 respectively (mean 0.823 Ϯ 0.018). However regarding ovarian desensitization in IVF cycles, it endometrial thickness (ET), the hormones (FSH, LH, progesterone), ovarian volume (OV right and left) and the Doppler is imperative that patients not adequately suppressed are identified. This would prevent continuation of the treatment parameters (RI, PI, PSV and TAMX), for the right and left ovarian and uterine arteries. Each table demonstrates the cycle before satisfactory down-regulation occurs. It is therefore more important to have high specificity than sensitivity in relationship between sensitivity and specificity for satisfactory down-regulation using oestrogen concentrations of developing cut-off values for test values. Increasing specificity to 100% (i.e. identifying all non-adequately suppressed women with a low false positive rate) decreases sensitivity of the tests, with the result of altered cut-off values of 0.892 and 0.842 (mean 0.867 Ϯ 0.025) as shown in Table V .
Discussion
Pituitary desensitization has become an integral part of assisted reproduction treatment, yet not enough is known about the changes in the blood flow of pelvic organs that are associated with this important phase of the cycle. This study demonstrates that all Doppler parameters measured in the ovarian and uterine vessels are significantly altered with GnRH analogues and that when the RI, PI, PSV and TAMX are compared, RI has the highest sensitivity and Ovarian blood flow can be studied either as the ovarian were no significant differences between the two analogues.
artery courses towards the substance of the ovary (Kurjak and RI ϭ resistance index; PI ϭ pulsatility index; PSV ϭ peak systolic velocity; TAMX ϭ time average maximum velocity. Kupesic, 1995) or by analysing the artery within the ovary There were no significant differences in either the baseline or pre-stimulation Doppler pulsatility index or peak systolic velocity when comparing the age groups.
itself, i.e. intra-ovarian/stromal flow. The technique for measurto significantly increase uterine artery RI after 2-4 months of therapy (Aleem and Predanic, 1995; . ing intra-ovarian blood flow is well described and involves assessing each ovary by studying 'any small artery in the Agonist treatment creates a state of gonadotrophin desensitization and ovarian suppression with a subsequent ovarian stroma not close to the surface of the ovary or near the wall of a follicle' (Zaidi et al., 1996) . No correction is hypo-oestrogenic state. Receptors for GnRH have been identified both in the ovary and the endometrium (Broekmans, made for the angle of insonation, because it cannot be determined for such small vessels. Hence the reproducibility 1996), but not in ovarian and uterine artery endothelium. Conversely, oestrogen receptors are widely distributed on the of pulsatility index measurements in intra-ovarian vessels has been questioned (Tekay and Joupilla, 1996) . smooth muscle cells of vessels (Perrot-Applanat, 1988) . Studies comparing pelvic blood flow with serum oestrogen conThe reports of GnRH analogue effects on intra-ovarian blood flow has not been consistent. Tekay and colleagues were centrations have been equivocal. Some have shown a good correlation (Goswamy et al., 1988; de Ziegler et al., 1991 ; able to detect intra-ovarian blood flow after 2 weeks of pituitary suppression with buserelin acetate in 10 out of 29 cases (34%) Weiner et al., 1993; Lunenfeld et al., 1996) while others found a poor correlation (Tekay et al., 1995) . In the current study (Tekay et al., 1995) , whereas Lunenfeld and co-workers (1996) detected intra-ovarian flow in only 9% of patients downlinear regression analysis showed a significant correlation (P Ͻ 0.05) between serum oestradiol and RI values in the regulated with a GnRH analogue (Lunenfeld et al., 1996) . For the above reasons only ovarian artery blood flow was ovarian arteries after down-regulation. Nevertheless multiple regression analysis of all the factors investigated showed investigated in the current study. It has been possible to obtain satisfactory reproducibility by eliminating inter-observer and endometrial thickness to be the most accurate independent predictor of pituitary suppression as measured by hypodiurnal variation and eliminating any side bias by studying the right and left ovarian arteries independently.
oestrogenism (oestradiol Ͻ130 pmol/l). RI of the ovarian arteries was the next best predictor and although the multiple By contrast, the measurement of uterine artery blood flow in most studies is generally uniform. The vessels are large and correlation coefficient statistic increased with the additive effect of RI and endometrial thickness, this was not statistically readily accessible allowing for ease of identification. Proof that GnRH agonists affect blood flow has already been established significant. Although some direct effect for GnRH analogues can thus be postulated by the changes in utero-ovarian blood (Matta et al., 1988; . GnRH analogue administration to women with uterine fibroids has been shown flow, it can be safely assumed to be principally a result of RI ϭ resistance index; PI ϭ pulsatility index; PSV (cm/s) ϭ peak systolic velocity; TAMX (cm/s) ϭ time average maximum velocity. ROC ϭ receiveroperating characteristic. NS ϭ not significant.
increase in uterine artery PI after down-regulation with GnRH ovarian arteries and this may be due to the fact that these larger arteries may be less sensitive to the hormonal effects of RI ϭ resistance index; PI ϭ pulsatility index; PSV (cm/s) ϭ peak systolic velocity; TAMX (cm/s) ϭ time average maximum velocity.
GnRH analogues.
NS ϭ not significant.
The changes in ovarian volume that occur over the downregulation period were also investigated. Ovarian volume as a measure of ovarian reserve has been shown to be predictive of IVF outcome (Syrop et al., 1995; Lass et al., 1997) . A the hypo-oestrogenism caused by pituitary desensitization. Furthermore though there may have been possible bias in significant decrease in ovarian volume in both the right and left ovaries after GnRH analogue administration (P Ͻ 0.001) evaluating baseline parameters ഛ3 days from the start of GnRH analogue administration we do not believe this to be was shown. This finding is not in agreement (Sharara et al., 1999) , where ovarian volume changes were studied in 38 significant because of the short time interval.
This study confirms that the overall effect of GnRH anapatients pre-treated with oral contraceptives for 3 weeks (range 3-6 weeks), prior to leuprolide acetate (LA) administration logues is to reduce blood flow to the target organs, mainly the uterus and ovaries (Table II) . This finding contradicts a report for 21 days. They concluded that pituitary desensitization with LA had no effect on ovarian volume measurements, but their (Cacciatore et al., 1990) where no change in uterine blood flow after 2-4 weeks of down-regulation in their study was cohort of patients already had suppressed inactive ovaries due to the oral contraceptive pill and they had not excluded women detected. Paradoxically another study (Bassil et al., 1995) describes low uterine RI values after 2-3 weeks of downwith PCO. In two studies (Farquhar et al., 1994; Wu et al., 1998) , it has been shown that patients with PCO have larger regulation with an increase after the fourth week, despite the commencement of gonadotrophin stimulation.
ovaries than non-PCO controls. Furthermore it has been shown that oral contraception significantly reduces ovarian volume In later work (Bassil et al., 1997 ) the authors were able to demonstrate a low mean intra-ovarian RI of 0.53 after the (Christensen et al., 1997) . These confounding factors may have introduced bias into their ovarian volume measurements. same period of pituitary suppression, with an increase in ovarian artery resistance after initiating human menopausal Studies investigating predictors of IVF treatment outcome have shown a relationship between increased female age, gonadotrophin (HMG). They concluded that administration of GnRH analogue increases the ovarian RI. However the increase higher basal FSH concentrations and reduced ovarian volume with an overall poorer outcome (Toner et al., 1991; Scott and in RI occurred during gonadotrophin administration and increased oestrogen secretion, somewhat contrary to the known Hoffman, 1995). In the current study no significant correlation was found between the change in ovarian volume with downand established effects of oestrogen on smooth vessel musculature and blood flow. Oestrogens have been shown to cause regulation and the change in Doppler measurements over the same time period. Whether percentage reduction in ovarian vasodilatation and decreased impedance to blood flow (Resnik et al., 1974; Hutchison et al., 1997; Cagnacci et al., 2000) .
volume and Doppler measurements with GnRH analogues can be used prognostically in assessing ovarian reserve remains to Furthermore, in the study by Bassil et al. (1997) no values for Doppler measurements were recorded prior to analogue be investigated. In a previous report it was shown that by 21 days there is administration and thus it is difficult to determine how the increase in RI as a direct result of GnRH analogue was comparable suppression of ovarian hormones by nafarelin and buserelin (Dada et al., 1999) . In this study it was found that calculated.
The results of the current study agree in part with other both of these drugs cause similar blood flow changes in both the uterine and ovarian vasculature during the down-regulation work (Engmann et al., 1999) . This group was able to show a significant decline in ovarian stromal flow velocity after 2-3 phase. Larger study groups are required to confirm these findings. weeks of GnRH agonist administration but were unable to show a similar reduction in the uterine blood flow during Female partner's age is an established prognostic indicator of treatment outcome in assisted conception (Check et al. , the same period. The results presented here are more in agreement with Battaglia et al. (1997) , who demonstrated an 1994). In the current study no evidence was found of a more
